Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Minority Interest (2018 - 2021)

Amphastar Pharmaceuticals (AMPH) has 4 years of Minority Interest data on record, last reported at $45.2 million in Q2 2021.

  • For Q2 2021, Minority Interest changed N/A year-over-year to $45.2 million; the TTM value through Jun 2021 reached $45.2 million, changed N/A, while the annual FY2020 figure was $46.4 million, 0.55% up from the prior year.
  • Minority Interest reached $45.2 million in Q2 2021 per AMPH's latest filing, roughly flat from $45.4 million in the prior quarter.
  • Across five years, Minority Interest topped out at $46.4 million in Q4 2020 and bottomed at $21.9 million in Q3 2018.
  • Average Minority Interest over 4 years is $42.0 million, with a median of $45.3 million recorded in 2019.
  • Peak YoY movement for Minority Interest: surged 102.47% in 2019, then fell 1.0% in 2021.
  • A 4-year view of Minority Interest shows it stood at $31.9 million in 2018, then soared by 44.6% to $46.2 million in 2019, then rose by 0.55% to $46.4 million in 2020, then dropped by 2.56% to $45.2 million in 2021.
  • Per Business Quant database, its latest 3 readings for Minority Interest were $45.2 million in Q2 2021, $45.4 million in Q1 2021, and $46.4 million in Q4 2020.